Stay updated on Study CB-839 + Paclitaxel in TNBC: Clinical Trial
Sign up to get notified when there's something new on the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page.

Latest updates to the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page
- CheckyesterdayChange DetectedNo substantive changes to the study details are detected; the screenshots show only minor formatting and layout differences without affecting core information such as status, eligibility, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check8 days agoNo Change Detected
- Check30 days agoChange DetectedAdded a government-status notice and updated version to v3.2.0; removed reference to v3.1.0.SummaryDifference3%

- Check37 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check51 days agoChange DetectedUpdated the page from Revision: v3.0.1 to Revision: v3.0.2; removed the 'Back to Top' element.SummaryDifference0.2%

- Check58 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.2%

- Check65 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific facility names and locations, as well as new chemical and medical terms related to skin and connective tissue diseases. Notably, the revision number has been updated to v3.0.0.SummaryDifference3%

Stay in the know with updates to Study CB-839 + Paclitaxel in TNBC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page.